Prokidney (PROK) Interest Coverage Ratio (2021 - 2026)
Prokidney (PROK) reported Interest Coverage Ratio of 2995.53 for Q1 2026, down 103.41% quarter-over-quarter from 87884.0 in Q4 2025.
Prokidney (PROK) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Interest Coverage Ratio data on file, last reported at 2995.53 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 2995.53, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 1857.74 (up 92.97% YoY), and the FY2025 annual result was 7938.0, up 61.1% from the prior year.
- Interest Coverage Ratio retreated to 2995.53 in Q1 2026 per PROK's latest filing, from 87884.0 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 87884.0 in Q4 2025 and troughed at 39709.0 in Q2 2025.
- A 5-year average of 8432.75 and a median of 13988.67 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio slumped 8060.42% in 2023, then jumped 440.83% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 15117.5 in 2022, then jumped by 46.62% to 8070.0 in 2023, then plunged by 219.52% to 25785.5 in 2024, then jumped by 440.83% to 87884.0 in 2025, then plunged by 103.41% to 2995.53 in 2026.
- Business Quant data shows PROK's Interest Coverage Ratio at 2995.53 in Q1 2026, 87884.0 in Q4 2025, and 19269.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -2,995.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,995.53 |
| Dec 31, 2025 | 87,884.00 |
| Sep 30, 2025 | -19,269.50 |
| Jun 30, 2025 | -39,709.00 |
| Dec 31, 2024 | -25,785.50 |
| Sep 30, 2024 | -24,486.50 |
| Jun 30, 2024 | -14,352.00 |
| Mar 31, 2024 | -20,038.00 |
| Dec 31, 2023 | -8,070.00 |
| Sep 30, 2023 | -23,308.50 |
| Jun 30, 2023 | -9,954.75 |
| Mar 31, 2023 | -13,625.33 |
| Dec 31, 2022 | -15,117.50 |
| Sep 30, 2022 | -1,226.62 |
| Jun 30, 2022 | -121.99 |
| Mar 31, 2022 | -4,747.29 |
| Sep 30, 2021 | -17,081.00 |